Skip to main content
INCYTE CORP logo

INCYTE CORP — Investor Relations & Filings

Ticker · INCY ISIN · US45337C1027 LEI · 549300Z4WN6JVZ3T4680 US Manufacturing
Filings indexed 1,784 across all filing types
Latest filing 2026-04-28 Annual Report
Country US United States of America
Listing US INCY

About INCYTE CORP

https://www.incyte.com/

Incyte Corporation is a global biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. The company is dedicated to finding innovative solutions for serious unmet medical needs through scientific research and development. Its primary areas of focus include oncology, hematology, inflammation, and dermatology. Incyte builds and maintains a diversified portfolio of marketed products and clinical candidates, primarily consisting of novel small molecule drugs and biologics, with the goal of improving patient outcomes.

Recent filings

Filing Released Lang Actions
ARS - INCYTE CORP (0000879169) (Filer)
Annual Report
2026-04-28 English
DEF 14A - INCYTE CORP (0000879169) (Filer)
Proxy Solicitation & Information Statement
2026-04-28 English
10-Q - INCYTE CORP (0000879169) (Filer)
Interim / Quarterly Report
2026-04-28 English
8-K - INCYTE CORP (0000879169) (Filer)
Regulatory Filings
2026-04-28 English
SCHEDULE 13G/A - INCYTE CORP (0000879169) (Subject)
Major Shareholding Notification
2026-03-27 English
8-K - INCYTE CORP (0000879169) (Filer)
Regulatory Filings
2026-03-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.